Offer - Urjas Oil for just ₹ 1 X
Toritz is a commercial drug that is prescribed in the form of Injection. Primarily, it is used for the treatment of Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia. Secondary and off-label uses of Toritz have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Toritz. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
The side effects typically associated with Toritz include Weakness. Besides the aforementioned side effects, there are other adverse effects of Toritz as well, which are listed below. Normally, these side effects of Toritz are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
In addition, Toritz's effect is Moderate during pregnancy and Severe for lactating mothers. It is important to know if Toritz has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Toritz related warnings section.
Toritz is not recommended if you suffer from certain medical conditions as it can have adverse effects. Hyperkalemia are examples of such conditions. Some other conditions that can be affected by Toritz are listed in the contraindications section below.
Additionally, Toritz may also adversely react with other medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Toritz is not safe while driving, and is is not addictive in nature.
Toritz is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Toritz safe for pregnant women?
Toritz can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Toritz right away. Take your doctor's advice before taking it again.
Is the use of Toritz safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Toritz. It should only be taken after medical advice.
What is the effect of Toritz on the Kidneys?
Toritz can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Toritz on the Liver?
There are no any side effects of Toritz on the liver.
What is the effect of Toritz on the Heart?
You may experience side effects on your heart after taking Toritz. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
Toritz should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Toritz unless your doctor advises you to do so -
Is this Toritz habit forming or addictive?
No, there is no any evidence that Toritz is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Toritz can make you feel drowsy.
Is it safe?
Toritz should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Toritz cannot treat any kind of mental disorder.
Interaction between Food and Toritz
Taking Toritz with food does not harm your health.
Interaction between Alcohol and Toritz
Due to lack of research, there is no information about the side effects of taking Toritz with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rituxan (rituximab)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1106-1109
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 872